Consulting agreement under which Mr. Pyott served as an advisor to the Company, with annual cash compensation, an option and RSUs
| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Bobak Azamian
Also a director
President, Chief Executive Officer and Chairman
|
48 | Not stated | $6,617,979 | |
|
Seshadri Neervannan
Chief Operating Officer
|
57 |
Since 2020
6 years
|
$2,628,172 | |
|
Aziz Mottiwala
Chief Commercial Officer
|
48 |
Since 2020
6 years
|
Not reported | |
|
Bryan Wahl
General Counsel and Secretary
|
48 | Not stated | $2,560,205 | |
|
Dianne Whitfield
Chief Human Resources Officer
|
49 |
Since 2021
5 years
|
Not reported | |
|
Elizabeth Yeu-Lin
Chief Medical Officer
|
47 |
Since 2024
2 years
|
Not reported | |
|
Neera Clase
Chief Commercial Officer
Title from the Form 4 dated Nov 3, 2026
|
Not stated | Not stated | Not reported | |
|
Jeffrey Farrow
See Remarks
Title from the Form 4 dated Jun 15, 2026
|
64 | Not stated | $2,677,617 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Consulting agreement under which Mr. Pyott served as an advisor to the Company, with annual cash compensation, an option and RSUs
Company purchased preferred stock in a private eye care company (April 2024 and December 2025 investments; Dr. Link, a Board member, also serves on that company's board)
Loading...